Developing next generation immunotherapeutics until the stage of clinical evaluation; Research on host tumor interaction; novel antibodies and peptide vaccines
Tübingen, Germany
Joined October 2021
- Tweets268
- Following340
- Followers334
- Likes1.3K
Pinned Tweet
After many years on Twitter/X, it is time to say goodbye - we will continue posting on our research on #LinkedIn
PhD position in Immunology of #Endometriosis at Uni Hospital Tübingen! Join the ENDO-RELIEF project (65%, 3 years, with extension option).
Apply by 25.11.2024.
More info: jobs.medizin.uni-tuebingen.d…
#PhDPosition #Immunology #Endometriosis #ResearchJobs #jobalert #hiring
Our wakeboarding trip couldn’t happen this year, but the team still had a great time. Thanks to Jonas and Melly for organizing!
#teamspirit #bbq
Announcing August Lab #TourDeForce Champs:
- Martina Lutz: 🎽🟡Bispecific checkpoint inhibitors
- Jonas Mauermann: 🎽🟢 Lightning-fast cytotoxicity assays
- Nisha Prakash: 🎽⚪️🔴 Tetramer staining success
- @KlimovichBoris: 🎽🦅 Superagonistic T cell engagers
🎉Celebrating our annual White Party together with @LabWalz.🎉
Proud to announce the ennoblement of Lady Juliane and Lord Helmut of the Glen!
#Tuebingen
Glad to announce our ACE2-M fusion protein, effective against SARS-CoV-2 escape variants, won the #Science2Start award! Congrats Dr. Latifa Zekri and team!
#BioRegioSTERN
bioregio-stern.de/de/presse/…
Translational Immunology retweeted
Now online - check out this video from @StrubeStiftung where @JulianeWalz introduces our new phase I #ClinicalTrial for an #immunopeptidomics-based #peptide #vaccine for #patients with #AML.
youtube.com/watch?v=tFuY4XU_…
✨Thrilled to share our new paper on Novel B7-H3 #CD276 #antibody in #AML published in @Cancers_MDPI!
Congrats to our #PhD student @S_Stefanczyk, @Lsfm3DNSCsClara and the team led by Melanie Märklin @MMaerklin! @MDPIOpenAccess @CoE_iFIT
mdpi.com/2857480
The Lab #TourDeForce June champs:
- Polina Kaidun 🟡🎽 for novel #Tcell constructs
- Britta Statz 🟢🎽for screening of #bispecific costimulators
- Martina Lutz ⚪️🔴🎽 for target restricted checkpoint inhibitors
- Nisha Prakash Eddie the 🦅🎽 for perseverance despite no new data
Translational Immunology retweeted
Our Teams (@LabWalz and @Salihlab) are looking forward to this upcoming #event fostering bench to bedside translation.
ekfs.de/aktuelles/veranstalt…
Translational Immunology retweeted
We are starting a phase-I #clinicaltrial for our #peptide #vaccine against acute myeloid leukemia (AML). We are
looking for #AML #patients after first-line therapy and aim to avoid relapse due to minimal residual disease.
For more information, check out:
medizin.uni-tuebingen.de/de/…
Translational Immunology retweeted
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers. A study by @Salihlab & others in @MolTherapy #ASCO24 hubs.li/Q02yvLpR0
Translational Immunology retweeted
Happy and proud to be part of the ENDO-RELIEF project in collaboration with @MMaerklin from @Salihlab supported by the @BMBF_Bund aiming to better understand the development of #endometriosis.
gesundheitsforschung-bmbf.de…
🏆 May Lab #TourDeForce Heroes! 🎉
🟡🎽Tatjana Schreiber leads with precision in mentoring
🟢🎽Emma Nill excels in #bispecific constructs cloning
⚪️🔴🎽Nisha Prakash masters experimental optimization of #Tcells
Polina Kaidun bravely tackles hurdles with the Eddie the 🦅🎽 spirit!
💫 Exciting news! Our B7H3xCD3 #bispecific #antibody CC-3 shows promise in fighting bone & soft tissue sarcomas. Congrats to Samuel Holzmayer & team! @MMaerklin @CoE_iFIT #immunotherapy
➡️frontiersin.org/journals/imm…
🏆 April Lab #TourDeForce Champs! 🎉 -@KlimovichBoris 🟡🎽 pioneering anticancer breakthroughs
-Polina Kaidun races in 🟢🎽 for innovation
-Nisha Prakash ⚪️🔴🎽conquers experimental frontiers
-Emma Nill 🦅🎽tackles cell culture hurdles with Eddie the Eagle spirit! – at Tübingen, Deutschland
Excited to share our latest study "Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody" in @BloodCancerJnl. Congrats to @S_Stefanczyk @MMaerklin and all contributors! 🎉 #AML #Leukemia #immunotherapy #ADCC
nature.com/articles/s41408-0…
Happy to see the latest study of Samuel Holzmayer and @KauerJoe et al on the effect of Asciminib on Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts published in @Cancers_MDPI 👏🏻
@MMaerklin
mdpi.com/2728576 – at Tübingen, Deutschland